Chroma Therapeutics' Series B - II Round

Chroma Therapeutics raised a round of funding on December 01, 2004. Investors include Essex Woodlands.

Chroma Therapeutics is a biotechnology company founded to exploit the potential of chromatin biology for cancer drug discovery. Chroma is focused on the identification of anti-cancer agents that combi…

Articles about Chroma Therapeutics' Series B - II Round: